Remove 2026 Remove Compounding Remove Drug Development
article thumbnail

Sionna Therapeutics secures $182m for cystic fibrosis drug development

Pharmaceutical Business Review

Additionally, Sionna is progressing with the development of compounds targeting complementary mechanisms. This capital raise provides financial flexibility positioning us to execute our clinical development plan with funding through 2026 and multiple value-creating clinical readouts.”

article thumbnail

Biopharmaceutical bioseparation systems market to value $20bn

European Pharmaceutical Review

billion by 2026, achieving a compound annual growth rate (CAGR) of 13.2 Advancements are underway in terms of product developments and innovations, with significant emphasis being placed on optimising and streamlining existing methods. percent CAGR between 2022 and 2026.

Dosage 111
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Orphan drugs’ financial success raises questions

pharmaphorum

Evaluate Pharma’s recent Orphan Drug Report subtitled its overview of the market ‘Niche no longer.’ This is based on the relative success orphan drugs have achieved, in terms of the number of approvals and the sales figures achieved for this area.

article thumbnail

Cloud Computing for Pharma: The Road to Digital Transformation 

Viseven

When COVID hit, the urgent need to accelerate drug development meant shrinking timelines from years to months, with no room for compromises on quality. This innovative approach has brought more than 40 successful drug discovery projects to AstraZeneca. By the end of 2026, the company will be able to analyze two million genomes.

article thumbnail

SMi’s 22nd Annual Pain Therapeutics Conference

pharmaphorum

Novel Compounds and Treatments for Pain: Opioids and the Alternatives. Million by 2026, growing at a CAGR of 4.40 % from 2019 to 2026. Analgesic pre-clinical development. Drug development. Exploratory development. Sponsored by: CHDR. Million in 2018 and is projected to reach USD 15.87